/Investor DB

Pace Ventures — 2024 Investments

4 investments dated 2024 · listed companies and verified rows first · show all

Clearlyclearly.helpAug 2024 · $4.3M

Clearly is an online platform that matches users with verified psychologists and provides tools to support therapy between sessions.

Digital HealthHealthtechMarketplacesMental Health

Dima Kovalenko(Founder)in

Co-investorsPragmatechPurple VenturesArgon VenturesBasis Set VenturesCrosspoint Capital PartnersM1720+4 more

Duniadunia.aiin𝕏Oct 2024 · $11.5M

Dunia operates an autonomous laboratory platform that combines physics-informed AI, robotic automation, and a large-scale experimental data engine in a closed-loop Design-Make-Test-Analyze cycle to discover and optimize materials such as electrochemical catalysts.

AI & Machine LearningDeep TechNew Materials

Marcus Tze-Kiat Ng(Founder)in

PartnerMarius Swart· solo GP

Co-investorsDeep Science VenturesElaiaKindred CapitalThird DerivativeEICredalpine

Holobiome, Inc.holobiome.orgin𝕏Oct 2024

Holobiome discovers and develops therapies derived from the human gut microbiome, working to translate microbiome science into probiotics and targeted treatments for whole-body health.

AI & Machine LearningBiotechHealthtechLongevityBoston, US

Philip Strandwitz(Co-founder & Director, Chief Executive Officer)inKim Lewis(Co-founder, Director)Mike La Fleur(President, Co-founder, Director)Michael LaFleur(Executive Officer)

BoardJoan LaRovere(Director)inIain Chessell(Director)

PartnerMarius Swart· solo GP

Co-investorsAble PartnersAstanor VenturesBantam GroupDeep FutureHealthtech CapitaliSelect Fund+4 more

Turnover Labsturnoverlabs.cominOct 2024 · $1.4M

Turnover Labs builds a durable electrolysis system that converts dilute CO2 emissions into pure, high-value chemical products on-site at any scale.

CleantechClimate TechNew Materials

Marissa Beatty(Founder & CEO)in

PartnerMarius Swart· solo GP

Co-investorsCollaborative FundGC Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.